Abnormalities, Drug-Induced
"Abnormalities, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Descriptor ID |
D000014
|
| MeSH Number(s) |
C16.131.042
|
| Concept/Terms |
Abnormalities, Drug-Induced- Abnormalities, Drug-Induced
- Abnormalities, Drug Induced
- Drug-Induced Abnormalities
- Abnormality, Drug-Induced
- Drug Induced Abnormalities
- Drug-Induced Abnormality
|
Below are MeSH descriptors whose meaning is more general than "Abnormalities, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Abnormalities, Drug-Induced".
This graph shows the total number of publications written about "Abnormalities, Drug-Induced" by people in this website by year, and whether "Abnormalities, Drug-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Abnormalities, Drug-Induced" by people in Profiles.
-
Comparison of rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects. Crit Rev Toxicol. 2016 11; 46(10):900-910.
-
Micro-CT imaging: Developing criteria for examining fetal skeletons in regulatory developmental toxicology studies - A workshop report. Regul Toxicol Pharmacol. 2016 Jun; 77:100-8.
-
The risk of congenital malformations associated with exposure to ?-blockers early in pregnancy: a meta-analysis. Hypertension. 2013 Aug; 62(2):375-81.
-
Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges. Birth Defects Res B Dev Reprod Toxicol. 2011 Aug; 92(4):333-44.
-
Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys. Birth Defects Res B Dev Reprod Toxicol. 2010 Aug; 89(4):326-38.
-
Effect of cocaine in early gestation on striatal dopamine and neurotrophic activity. Pediatr Res. 1993 Sep; 34(3):389-92.
-
Convulsive disorders: toxicity of anticonvulsants. Clin Neuropharmacol. 1991 Apr; 14(2):97-115.